ANKMJ
Ankyra Medical Journal

Ankyra Medical Journal (AnkMJ), formerly known as the Journal of Translational and Practical Medicine, regularly publishes international quality issues in the field of Medicine in the light of current information.

eISSN: 3023-655X
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
The effect of methylenetetrahydrofolate reductase polymorphisms on the methotrexate toxicity in children with acute lymphoblastic leukemia
Abstract
Aims: The enzyme of methylenetetrahydrofolate reductase (MTHFR) is fundamental for folate metabolism and has two common polymorphisms (C677T and A1298G). Methotrexate, which interrupts folate metabolism, is one of the backbone drugs of pediatric acute lymphoblastic leukemia (ALL). Methotrexate inhibits the synthesis of DNA replication.
Methods: In this study, we aimed to investigate the relationship between polymorphisms of the MTHFR gene and methotrexate toxicity. 85 children with newly diagnosed ALL were enrolled in the study. MTHFR gene polymorphisms and the toxicities related to methotrexate were evaluated.
Results: A total of 85 (54 females and 31 males) children were diagnosed with ALL. The allele frequencies for the FRG polymorphisms were as follows: MTHFR 677 CC 47 (55.3%), CT 29 (34.1%, TT 9 (10.6%) . No significant differences were detected with respect to event-free survival or toxicity between wild-type and other MTHFR variants.
Conclusion: Clinicians must be vigilant about the pharmacogenetic features of the patients. This study reveals that personalized medicine is the next future of treating ALL.

Keywords : Children, methotrexate, methylenetetrahydrofolate reductase, polymorphism, toxicity

Download Article


1. Inaba H, Pui CH. Advances in the diagnosis and treatment of pediatric acute lymphoblastic leukemia. J Clin Med 2021; 10: 1926.
2. Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica 2020; 105: 2524-39.
3. Micallef B, Nisticò R, Sarac SB, ey al. The changing landscape of treatment options in childhood acute lymphoblastic leukaemia. Drug Discov Today 2022; 27: 1483-94.
4. Kozminski P , Halik PK, Chesori R, Gniazdowska E. Overview of dual-acting drug methotrexate in different neurological diseases, autoimmune pathologies and cancers. Int J Mol Sci 2020; 21: 3483.
5. Maagdenberg H, Oosterom N, Zanen J, et al. Genetic variants associated with methotrexate-induced mucositis in cancer treatment: a systematic review and meta-analysis. Crit Rev Oncol Hematol 2021; 161: 103312.
6. Yazıcıoğlu B, Kaya Z, Güntekin Ergun S, et al. Influence of folate-related gene polymorphisms on high-dose methotrexate-related toxicity and prognosis in Turkish children with acute lymphoblastic leukemia. Turk J Haematol 2017; 34: 143-50.
7. Frikha R, Rebai T, Lobna BM, et al. Comprehensive analysis of Methylenetetrahydrofolate reductase C677T in younger acute lymphoblastic leukemia patients: a single-center experience. J Oncol Pharm Pract 2019; 25: 1182-6.
8. Torun YA, Patiroglu T, Ozdemir MA, Ozkul Y, Ekici A, Karakukcu M. Inherited prothrombotic risk factors in Turkish children with acute lymphoblastic leukemia: significance of concomitant genetic mutation. Clin Appl Thromb Hemost 2012; 18: 218-21.
9. Unal E, Mutlu FT, Karakukcu M. The importance of MTHFR polymorphisms in pediatric cerebral stroke. Childs Nerv Syst 2012; 28: 13.
10. Yuksel Soycan L. BFM-TR ALL 2000: first Turkish multicentric study in the treatment of pediatric acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2007; 29: 21.
11. Ozkul Y, Evereklioglu C, Borlu M, et al. 5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement. Br J Ophthalmol 2005; 89: 1634-7.
12. Akar N, Akar E, Ozel D, Deda G, Sipahi T. Common mutations at the homocysteine metabolism pathway and pediatric stroke. Thromb Res 2001; 102: 115-20.
13. Kenet G, Lütkhoff LK, Albisetti M, et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation 2010; 121: 1838-47.
Article available in :
Volume 1, Issue 1, 2022
Page : 9-13
https://doi.org/10.51271/JTPM-0010
Article Information
Received : 26 Jun 2022
Accepted : 29 Jun 2022
Published : 16 Jul 2022
Corresponding Author :

Ekrem Ünal: Department of Pediatric Hematology, Medical Point Gaziantep Hospital, Gaziantep, Türkiye

[email protected]
Citation : Yılmaz E, Özcan A, Gök V , Karakükcü M, Ünal E. The effect of methylenetetrahydrofolate reductase polymorphisms on the methotrexate toxicity in children with acute lymphoblastic leukemia. J Transl Pract Med 2022; 1(1): 9-13.

Read: 399
Download : 402
Cited: 1
_Footer